248 related articles for article (PubMed ID: 32657546)
1. Programmable CRISPR-Cas transcriptional activation in bacteria.
Ho HI; Fang JR; Cheung J; Wang HH
Mol Syst Biol; 2020 Jul; 16(7):e9427. PubMed ID: 32657546
[TBL] [Abstract][Full Text] [Related]
2. Engineered CRISPRa enables programmable eukaryote-like gene activation in bacteria.
Liu Y; Wan X; Wang B
Nat Commun; 2019 Aug; 10(1):3693. PubMed ID: 31451697
[TBL] [Abstract][Full Text] [Related]
3. Effective CRISPRa-mediated control of gene expression in bacteria must overcome strict target site requirements.
Fontana J; Dong C; Kiattisewee C; Chavali VP; Tickman BI; Carothers JM; Zalatan JG
Nat Commun; 2020 Apr; 11(1):1618. PubMed ID: 32238808
[TBL] [Abstract][Full Text] [Related]
4. CRISPathBrick: Modular Combinatorial Assembly of Type II-A CRISPR Arrays for dCas9-Mediated Multiplex Transcriptional Repression in E. coli.
Cress BF; Toparlak ÖD; Guleria S; Lebovich M; Stieglitz JT; Englaender JA; Jones JA; Linhardt RJ; Koffas MA
ACS Synth Biol; 2015 Sep; 4(9):987-1000. PubMed ID: 25822415
[TBL] [Abstract][Full Text] [Related]
5. Rational engineering of a modular bacterial CRISPR-Cas activation platform with expanded target range.
Villegas Kcam MC; Tsong AJ; Chappell J
Nucleic Acids Res; 2021 May; 49(8):4793-4802. PubMed ID: 33823546
[TBL] [Abstract][Full Text] [Related]
6. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors.
Piatek A; Ali Z; Baazim H; Li L; Abulfaraj A; Al-Shareef S; Aouida M; Mahfouz MM
Plant Biotechnol J; 2015 May; 13(4):578-89. PubMed ID: 25400128
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants.
Ding X; Yu L; Chen L; Li Y; Zhang J; Sheng H; Ren Z; Li Y; Yu X; Jin S; Cao J
Cells; 2022 Sep; 11(19):. PubMed ID: 36231007
[TBL] [Abstract][Full Text] [Related]
8. A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9.
Cui L; Vigouroux A; Rousset F; Varet H; Khanna V; Bikard D
Nat Commun; 2018 May; 9(1):1912. PubMed ID: 29765036
[TBL] [Abstract][Full Text] [Related]
9. Orthogonal tuning of gene expression noise using CRISPR-Cas.
Wu F; Shim J; Gong T; Tan C
Nucleic Acids Res; 2020 Jul; 48(13):e76. PubMed ID: 32479612
[TBL] [Abstract][Full Text] [Related]
10. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
Liu Q; Zhang H; Huang X
FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Gene Circuits Combining CRISPR Interference and CRISPR Activation in
Barbier I; Kusumawardhani H; Chauhan L; Harlapur PV; Jolly MK; Schaerli Y
ACS Synth Biol; 2023 Oct; 12(10):3064-3071. PubMed ID: 37813387
[TBL] [Abstract][Full Text] [Related]
12. Controlling and enhancing CRISPR systems.
Shivram H; Cress BF; Knott GJ; Doudna JA
Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
[TBL] [Abstract][Full Text] [Related]
13. Short communication: An inducible CRISPR/dCas9 gene repression system in Lactococcus lactis.
Xiong ZQ; Wei YY; Kong LH; Song X; Yi HX; Ai LZ
J Dairy Sci; 2020 Jan; 103(1):161-165. PubMed ID: 31733872
[TBL] [Abstract][Full Text] [Related]
14. Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex.
He M; Zhou X; Li Z; Yin X; Han W; Zhou J; Sun X; Liu X; Yao D; Liang H
J Am Chem Soc; 2022 Jul; 144(28):12690-12697. PubMed ID: 35792375
[TBL] [Abstract][Full Text] [Related]
15. Uncovering the Distinct Properties of a Bacterial Type I-E CRISPR Activation System.
Villegas Kcam MC; Tsong AJ; Chappell J
ACS Synth Biol; 2022 Feb; 11(2):1000-1003. PubMed ID: 35077145
[TBL] [Abstract][Full Text] [Related]
16. A CRISPR Interference Platform for Efficient Genetic Repression in
Wensing L; Sharma J; Uthayakumar D; Proteau Y; Chavez A; Shapiro RS
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760609
[TBL] [Abstract][Full Text] [Related]
17. A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer.
Liu C; Wang N; Luo R; Li L; Yang W; Wang X; Shen M; Wu Q; Gong C
Theranostics; 2021; 11(20):9833-9846. PubMed ID: 34815789
[TBL] [Abstract][Full Text] [Related]
18. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems.
Davidson AR; Lu WT; Stanley SY; Wang J; Mejdani M; Trost CN; Hicks BT; Lee J; Sontheimer EJ
Annu Rev Biochem; 2020 Jun; 89():309-332. PubMed ID: 32186918
[TBL] [Abstract][Full Text] [Related]
19. Multiplex and optimization of dCas9-TV-mediated gene activation in plants.
Xiong X; Liang J; Li Z; Gong BQ; Li JF
J Integr Plant Biol; 2021 Apr; 63(4):634-645. PubMed ID: 33058471
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary and mechanistic diversity of Type I-F CRISPR-associated transposons.
Klompe SE; Jaber N; Beh LY; Mohabir JT; Bernheim A; Sternberg SH
Mol Cell; 2022 Feb; 82(3):616-628.e5. PubMed ID: 35051352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
